Predictors and trajectories of fear of cancer recurrence in Chinese breast cancer patients

被引:8
|
作者
Yang, Yuan [1 ]
Qi, Han [2 ,3 ,4 ]
Li, Wengao [5 ]
Liu, Ting [6 ]
Xu, Wenjing [7 ,8 ]
Zhao, Shunzhen [8 ]
Yang, Fan [1 ]
Humphris, Gerry [9 ]
Chen, Yu [10 ]
Sun, Hengwen [8 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Mental Hlth Ctr, Guangzhou 510080, Peoples R China
[2] Capital Med Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100000, Peoples R China
[3] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing 100000, Peoples R China
[4] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100000, Peoples R China
[5] Guangdong 999 Brain Hosp, Dept Psychiat, Guangzhou 510515, Peoples R China
[6] Southern Med Univ, Naang Hosp, Dept Psychiat, Guangzhou 510515, Peoples R China
[7] Southern Med Univ, Sch Clin Med 2, Guangzhou 510515, Peoples R China
[8] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Canc Ctr, Guangzhou 510080, Peoples R China
[9] Univ St Andrews, Med Sch, Div Populat & Behav Sci, St Andrews KY16 9TF, Scotland
[10] Southern Med Univ, Sch Nursing, Guangzhou 510515, Peoples R China
关键词
Breast cancer; Fear of cancer recurrence; Longitudinal; Predictors; Trajectory; PSYCHOLOGICAL DISTRESS; YOUNG-WOMEN; ANXIETY; HISTORY; PROGRESSION; PREVALENCE; SURVIVORS; SYMPTOMS; ADULT; AGE;
D O I
10.1016/j.jpsychores.2023.111177
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Fear of cancer recurrence (FCR) is one of the most common and aversive psychological phenomena among cancer patients. This study explored the trajectories of FCR over the 18 months following discharge, and evaluated the associations between baseline demographic and clinical variables and FCR trajectories among Chinese women treated for breast cancer. Methods: This is a longitudinal prospective study. All participants were asked to completed a battery of ques-tionnaires (FCR-7, PHQ-9, GAD-7 and MPQ-VAS) at baseline, 6, 12, and 18 months after discharge. Generalized linear mixed model and group-based trajectory analyses were conducted.Results: Three hundred women with breast cancer were recruited. Latent class growth modeling analysis showed that three-group trajectory solution was the best fitting (i.e., 'intermediate level-stable group' (63.3%), 'low level-increasing group' (18.3%), and 'high level-decreasing group' (18.3%). Patients reported significant higher FCR at baseline assessment compared to other time points. Significant positive associations were found between anxiety, depression and FCR. Patients who had no baseline depression (estimate =-2.14, 95% CI: - 2.78- (-1.51), P < 0.001) or anxiety (estimate =-2.77, 95% CI:-3.44-(-2.10), P < 0.001) tended to report sig-nificant lower FCRs over time. Women with none/mild life stress exhibited significant lower FCRs than those with moderate/high life stress, and participants with a family history of cancer or pessimism reported higher FCRs. Conclusion: >60% of the breast cancer women showed intermediate level-stable FCRs over the 18 months after discharge. Baseline anxiety, depression, life stress, family cancer history and pessimism predicts higher FCR levels. Clinical teams responsible for continuing patient care following treatment should develop clearer stra-tegies for management of FCR.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Trajectories of fear of recurrence in women with breast cancer
    Laura B. Dunn
    Dale J. Langford
    Steven M. Paul
    Molly B. Berman
    Dianne M. Shumay
    Kord Kober
    John D. Merriman
    Claudia West
    John M. Neuhaus
    Christine Miaskowski
    [J]. Supportive Care in Cancer, 2015, 23 : 2033 - 2043
  • [2] Trajectories of fear of recurrence in women with breast cancer
    Dunn, Laura B.
    Langford, Dale J.
    Paul, Steven M.
    Berman, Molly B.
    Shumay, Dianne M.
    Kober, Kord
    Merriman, John D.
    West, Claudia
    Neuhaus, John M.
    Miaskowski, Christine
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (07) : 2033 - 2043
  • [3] Trajectories of fear of cancer recurrence in young breast cancer survivors
    Schapira, Lidia
    Zheng, Yue
    Gelber, Shari
    Poorvu, Philip
    Ruddy, Kathryn J.
    Tamini, Rulla
    Peppercorn, Jeffrey
    Come, Steve
    Borges, Virginia
    Partridge, Ann
    Rosenberg, Shoshana
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [4] Trajectories of fear of cancer recurrence in young breast cancer survivors
    Schapira, Lidia
    Zheng, Yue
    Gelber, Shari, I
    Poorvu, Philip
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Peppercorn, Jeffrey
    Come, Steven E.
    Borges, Virginia F.
    Partridge, Ann H.
    Rosenberg, Shoshana M.
    [J]. CANCER, 2022, 128 (02) : 335 - 343
  • [5] Predictors and Patterns of Fear of Cancer Recurrence in Breast Cancer Survivors
    McGinty, Heather L.
    Small, Brent J.
    Laronga, Christine
    Jacobsen, Paul B.
    [J]. HEALTH PSYCHOLOGY, 2016, 35 (01) : 1 - 9
  • [6] Trajectories of fear of cancer recurrence and its influence factors: A longitudinal study on Chinese newly diagnosed cancer patients
    Chen, Furong
    Ou, Meijun
    Xiao, Zhirui
    Xu, Xianghua
    [J]. PSYCHO-ONCOLOGY, 2024, 33 (01)
  • [7] High Fear of Cancer Recurrence in Chinese Newly Diagnosed Cancer Patients
    Luo, Xian
    Li, Wengao
    Yang, Yuan
    Humphris, Gerald
    Zeng, Lijuan
    Zhang, Zijun
    Garg, Samradhvi
    Zhang, Bin
    Sun, Hengwen
    [J]. FRONTIERS IN PSYCHOLOGY, 2020, 11
  • [8] Predictors of fear of recurrence in cancer survivors
    Love-Ghaffari, Melissa H.
    Zhao, Luhua
    Smith, Tenbroeck
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S150 - S150
  • [9] Role of peer support on fear of cancer recurrence in patients with breast cancer
    Wang, Yue-Zhen
    Li, Ling
    Pang, Zi-Lei
    [J]. JOURNAL OF ADVANCED NURSING, 2024,
  • [10] Prevalence and predictors of fear of recurrence among adult patients with cancer
    Rabin, Julia
    Perez, Giselle K.
    Hall, Daniel L.
    Hagan, Teresa
    Quain, Katharine
    Jimenez, Rachel
    Park, Elyse R.
    Peppercorn, Jeffrey
    [J]. PSYCHO-ONCOLOGY, 2017, 26 : 75 - 75